Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2‐related programmed cell death in an AMPK‐dependent manner
Open Access
- 29 April 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (12), 6670-6679
- https://doi.org/10.1111/jcmm.15318
Abstract
Cardiovascular diseases such as myocardial ischaemia have a high fatality rate in patients with diabetes. This study was designed to expose the crosstalk between oxidative stress and AMPK, a vital molecule that controls biological energy metabolism, in myocardial ischaemia reperfusion injury (I/RI) in diabetic rats. Diabetes was stimulated in rats using streptozotocin injection. Rats were separated on random into control, control + I/R, Diabetes, Diabetes + I/R, Diabetes + I/R + N‐acetylcysteine and Diabetes + I/R + Vas2870 groups. Myocardial infarct size was determined, and the predominant Nox family isoforms were analysed. In vitro, the H9C2 cells were administered excess glucose and exposed to hypoxia/reoxygenation to mimic diabetes and I/R. The AMPK siRNA or AICAR was used to inhibit or activate AMPK expression in H9C2 cells, respectively. Then, myocardial oxidative stress and programmed cell death were measured. Diabetes or high glucose levels were found to aggravate myocardial I/RI or hypoxia/reoxygenation in H9C2 cells, as demonstrated by an increase in myocardial infarct size or lactate dehydrogenase levels, oxidative stress generation and induction of programmed cell death. In diabetic rat hearts, cardiac Nox1, Nox2 and Nox4 were all heightened. The suppression of Nox2 expression using Vas2870 or Nox2‐siRNA treatment in vivo or in vitro, respectively, protected diabetic rats from myocardial I/RI. AMPK gene knockout increased Nox2 protein expression while AMPK agonist decreased Nox2 expression. Therefore, diabetes aggravates myocardial I/RI by generating of Nox2‐associated oxidative stress in an AMPK‐dependent manner, which led to the induction of programmed cell death such as apoptosis, pyroptosis and ferroptosis.Keywords
Funding Information
- National Natural Science Foundation of China (81801947)
This publication has 37 references indexed in Scilit:
- Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementAntioxidants and Redox Signaling, 2015
- NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cellsToxicology and Applied Pharmacology, 2013
- NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-α-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cellsToxicology and Applied Pharmacology, 2013
- An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathyInternational Journal of Cardiology, 2013
- Executive Summary: Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Mechanisms of Cell Death in Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- The NOX toolbox: validating the role of NADPH oxidases in physiology and diseaseCellular and Molecular Life Sciences, 2012
- Improved myocardial perfusion in chronic diabetic mice by the up‐regulation of pLKB1 and AMPK signalingJournal of Cellular Biochemistry, 2010
- Nutrient Stress Activates Inflammation and Reduces Glucose Metabolism by Suppressing AMP-Activated Protein Kinase in the HeartDiabetes, 2009
- Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects With Type 2 DiabetesDiabetes, 2007